Israeli-Dutch Biotech Raises €55M to Fight Huntington’s Disease and ALS
Prilenia Therapeutics has raised €55M in Series A funding to launch late-stage clinical trials of…
Prilenia Therapeutics has raised €55M in Series A funding to launch late-stage clinical trials of…
Barcelona-based SOM Biotech is developing treatments for incurable diseases such as Huntington’s disease with drugs…
Update (23/01/2019): The FDA has given uniQure regulatory clearance to begin a phase I/II trial…
Using a lab-on-a-chip device, Swiss scientists have found a way to diagnose the neurodegenerative condition…
A study run by Oxford BioDynamics suggests that we could predict Huntington's more easily by…
uniQure has raised a substantial public offering on the NASDAQ. The funding could help the Dutch…
Today, we're taking a look at Anima Biotech, an Israeli company that is developing a…
Polish researchers tested a new variant of CRISPR/Cas9 that increases the gene-editing system's precision in…
Rare diseases affect fewer than 1 in 2,000 people in Europe and less than 200,000…
Trim-Away removes a protein to uncover its true function, which will support disease research and potentially…
We've compiled a list of some of the latest advances of biotech in the field…
Last year was a bad year for biotech as an industry, but it was particularly…